News

IceCure Medical Receives Patent Notice for Cryoablation Tech

IceCure Medical Receives Patent Notice for Cryoablation Tech

IceCure Medical's Cryoablation Technology Sets New Standards

IceCure Medical Ltd. (Nasdaq: ICCM) has achieved a significant milestone by receiving an Intention to Grant Notice from the European Patent Office for its cutting-edge invention titled "Cryogenic System Connector." This innovative technology is part of the XSense™ system, designed to enhance safety and ensure the integrity of cryogenic procedures used in tumor ablation.

Innovative Features of XSense™ System

The XSense™ system's cryogenic connector represents a breakthrough in minimally-invasive cryoablation technology. This system, which has already garnered U.S. Food and Drug Administration clearance, holds promise for tackling additional indications in tumor ablation. The global tumor ablation market is projected to present significant growth opportunities, with an estimated value of approximately $1.67 billion.

CEO Insights on Growing Patent Portfolio

CEO Eyal Shamir expressed enthusiasm regarding the company's expanding intellectual property assets, emphasizing that this development reflects IceCure's leadership in the cryoablation sector. As Europe emerges as a critical market, IceCure has built relationships with key distributors. Independent clinical studies are underway, as medical professionals adopt IceCure’s advanced technology across various indications.

IceCure's Impact on Tumor Treatment

With a focus on treating both benign and cancerous tumors, IceCure Medical’s systems leverage liquid nitrogen to freeze tumors, offering a safe alternative to traditional surgical methods. The ProSense® system is integral to these efforts, marketed globally and cleared for various indications, affirming its role in contemporary therapeutic approaches.

Future Prospects in Cryoablation

Looking ahead, IceCure is poised for growth as it continues to innovate within the cryoablation landscape. The recent patent issuance will support the ongoing development and market adoption of their technologies. The potential to address unmet needs in treatment indicates a bright future for IceCure Medical as it pioneers advancements in this medical field.

Understanding the Role of Patents in Innovation

Patents play a crucial role in fostering innovation by providing companies with the security they need to invest in research and development. IceCure’s receipt of the Intention to Grant Notice is a testament to their innovative capabilities. By protecting its inventions, IceCure can continue to explore new treatments and technologies that could transform patient care.

Company Overview: IceCure Medical

IceCure Medical specializes in advanced cryoablation therapy systems designed for tumors. Their technology enables minimally invasive procedures that can be carried out efficiently, enhancing patient safety and recovery. By focusing on pivotal areas such as breast, kidney, bone, and lung cancers, IceCure is creating significant impacts in the treatment of various tumor types.

Frequently Asked Questions

What does the Intention to Grant Notice mean for IceCure Medical?

The Intention to Grant Notice signifies that IceCure Medical is one step closer to securing a patent for its cryogenic connector technology, enhancing its competitive edge in the market.

How does XSense™ technology improve cryoablation procedures?

XSense™ technology is designed to improve safety and maintain the cryogen’s integrity during the ablation process, resulting in better treatment outcomes.

What markets is IceCure targeting with its cryoablation technology?

IceCure is focusing on key markets including Europe and worldwide, aiming to expand its distribution network and clinical studies.

What types of tumors does IceCure's technology treat?

IceCure Medical’s technology is utilized for treating both benign and cancerous tumors, specifically targeting breast, kidney, bone, and lung cancers.

How is IceCure ranked in the cryoablation market?

IceCure Medical is considered a leader in cryoablation technology, bolstered by its growing portfolio of intellectual property and innovative products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 34

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 36

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 5

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 70

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 20

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
PAG, HOWL and PSNL Deals Face Fresh Shareholder Checks

Updated Category News Views 60

Three proposed takeovers, three very different headaches, and one familiar question that never gets old: are regular shareholders actually receiving the best available deal? On Nov. 20, 2026, investor-rights law firm Halper Sadeh LLC said it was investigating the proposed transactions involving Penske Automotive Group, Werewolf Therapeutics and Personalis for potential...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 83

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
SHEIN's EU Training Push Targets Seller Compliance Gaps

Updated Category News Views 72

Chemicals buried in a cheap handbag or kids' accessory can wreck a marketplace's credibility faster than any glossy campaign can repair it. That is the uncomfortable backdrop to SHEIN and SPEAC's November 19 session on EU chemical-safety rules for marketplace sellers. This was not a fashion trend webinar; it was a practical warning about high-risk substances, regulatory...

Continue Reading
Subsplash Builds a Broader Church Software Stack in 2026

Updated Category News Views 54

Church software has spent too many years behaving like a junk drawer, and Subsplash is plainly trying to replace it with one working system. The company used its November 18 Product Event in Dallas to show off releases from 2026 and preview two additions: Communications, due in December, and Subsplash Intelligence, targeted for early 2027. A Serious Push Beyond the Church...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 55

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategies for Maximizing Your Retirement with $1 Million

Updated Category News Views 148

Planning for a Comfortable Retirement with $1 Million Reaching the milestone of having $1 million saved in your IRA as you near your 70th birthday is a commendable accomplishment. However, to make sure this amount lasts throughout your retirement, which could extend over two decades, careful planning is essential. Effectively managing your retirement funds requires a good...

Continue Reading
Wells Fargo Downgrades SailPoint to Equalweight: What It Means

Updated Category News Views 116

Wells Fargo Downgrades SailPoint Technologies Holdings Wells Fargo has recently revised its stance on SailPoint Technologies Holdings (NYSE: SAIL), changing its investment rating from Overweight to Equalweight. Alongside this rating downgrade, the bank has also lowered its price target for the stock from $17 to $15. This shift indicates a more reserved outlook on the...

Continue Reading
Brunswick Exploration's Promising Lithium Recovery Results

Updated Category News Views 120

Promising Phase 1 Metallurgical Results from Brunswick Exploration Brunswick Exploration Inc. (TSX-V: BRW; OTCQB: BRWXF; Frankfurt: 1XQ) has exciting developments regarding its Mirage Project. The Montreal-based mineral exploration company is charting a significant course in extracting lithium through innovative methodologies. Recent preliminary metallurgical results from...

Continue Reading
Enhancing Bone Health: A New Partnership in Australia

Updated Category News Views 174

The Global Healthy Living Foundation Australia (GHLF Australia) forged a partnership with The Bone Bus back then, aiming to pump up bone health access in rural spots where folks were really struggling. This initiative wasn't just some PR stunt; it targeted real issues surrounding osteoporosis that so many older Australians faced. Rural Access: A Tough Nut to Crack Let’s...

Continue Reading
Kotak Securities Revises Target for Larsen & Toubro, Maintains Sell Rating

Updated Category News Views 176

Kotak Securities slammed the brakes on any bullish sentiment around Larsen & Toubro Ltd. (LT:IN) back in late 2024, despite raising their price target from INR3,150 to INR3,380. Now, this sounds like good news on paper—a bit of upward adjustment—but let’s not kid ourselves here. They slapped a Sell rating on it right alongside that shiny new number. What gives?...

Continue Reading